Skip to main content
. 2017 Aug 19;8(59):99541–99551. doi: 10.18632/oncotarget.20362

Figure 2. Cancer-specific survival rates of all included patients with appendiceal neuroendocrine malignancies by histologic subtype.

Figure 2

WDNET, well-differentiated neuroendocrine tumor; PDNEC, poorly differentiated neuroendocrine carcinoma; MHT, mixed histology tumor.